Abstract
Non-alcoholic fatty liver disease (NAFLD) is a common public health issue and is considered a main drive for liver diseases. However, the basic mechanisms that trigger the development of NAFLD still remain somewhat elusive. Endoplasmic reticulum (ER) stress facilitates the unfolded protein response (UPR) and contributes to the etiology of steatosis, nonalcoholic steatohepatitis and ultimately hepatocarcinoma. Although ER stress may lead to a cascade of compensatory responses that help to restore ER homeostasis, cell survival and adaptation, prolonged ER stress is known to impose detrimental pathological outcome, involving insulin resistance, ectopic fat deposition, inflammation, apoptosis, and dysregulated autophagy. All of these processes are capable of provoking the onset and development of NAFLD. To this end, it is pertinent to understand the role of ER stress in the onset and progression of NAFLD for proper management of this devastating metabolic disease. Here in this review, we will summarize available information on the recent advances in the potential role for ER stress in the etiology of NAFLD.
Keywords: ER stress, liver, non-alcoholic fatty liver disease, metabolic disease, unfolded protein response, autophagy.
Graphical Abstract
Current Drug Targets
Title:Endoplasmic Reticulum Stress Related Molecular Mechanisms in Nonalcoholic Fatty Liver Disease (NAFLD)
Volume: 19 Issue: 9
Author(s): Lifeng Wang, Junhua Chen, Chao Ning, Dongyu Lei and Jun Ren *
Affiliation:
- Center for Cardiovascular Research and Alternative Medicine, University of Wyoming College of Health Sciences, Laramie, WY 82071,United States
Keywords: ER stress, liver, non-alcoholic fatty liver disease, metabolic disease, unfolded protein response, autophagy.
Abstract: Non-alcoholic fatty liver disease (NAFLD) is a common public health issue and is considered a main drive for liver diseases. However, the basic mechanisms that trigger the development of NAFLD still remain somewhat elusive. Endoplasmic reticulum (ER) stress facilitates the unfolded protein response (UPR) and contributes to the etiology of steatosis, nonalcoholic steatohepatitis and ultimately hepatocarcinoma. Although ER stress may lead to a cascade of compensatory responses that help to restore ER homeostasis, cell survival and adaptation, prolonged ER stress is known to impose detrimental pathological outcome, involving insulin resistance, ectopic fat deposition, inflammation, apoptosis, and dysregulated autophagy. All of these processes are capable of provoking the onset and development of NAFLD. To this end, it is pertinent to understand the role of ER stress in the onset and progression of NAFLD for proper management of this devastating metabolic disease. Here in this review, we will summarize available information on the recent advances in the potential role for ER stress in the etiology of NAFLD.
Export Options
About this article
Cite this article as:
Wang Lifeng, Chen Junhua, Ning Chao, Lei Dongyu and Ren Jun*, Endoplasmic Reticulum Stress Related Molecular Mechanisms in Nonalcoholic Fatty Liver Disease (NAFLD), Current Drug Targets 2018; 19 (9) . https://dx.doi.org/10.2174/1389450118666180516122517
DOI https://dx.doi.org/10.2174/1389450118666180516122517 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Related Books

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Dexamethasone and Restenosis After Coronary Stent Implantation: New Indication for an Old Drug?
Current Pharmaceutical Design Editorial (Thematic Issue: Cell Metabolism and Current Challenges in Drug Research)
Current Pharmaceutical Design Biochemical Characterization of a New Maize (Zea mays L.) Peptide Growth Factor
Protein & Peptide Letters Amyloid Formation in Surfactants and Alcohols: Membrane Mimetics or Structural Switchers?
Current Protein & Peptide Science Integrated Biomarkers for Depression in Alzheimer’s Disease: A Critical Review
Current Alzheimer Research [11C]Meta-Hydroxyephedrine PET/CT
Current Radiopharmaceuticals New Anti-Anginal Drugs: Ranolazine
Cardiovascular & Hematological Agents in Medicinal Chemistry Microemulsions as Carriers for Therapeutic Molecules
Recent Patents on Drug Delivery & Formulation Harvesting New Therapeutic Avenues with Stem Cell Applications
Current Neurovascular Research Advanced Glycation: Implications in Tissue Damage and Disease
Protein & Peptide Letters Epidemiological Aspects of Seasonal and Pandemic Influenza in Recent Years and Emerging Viruses
Clinical Immunology, Endocrine & Metabolic Drugs (Discontinued) Estrogen Receptor-α: Plasma Membrane Localization and Functions
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Contact Allergy in Children with Atopic Dermatitis: A Retrospective Study
Endocrine, Metabolic & Immune Disorders - Drug Targets Nicotinamide Supplementation Protects Gestational Diabetic Rats by Reducing Oxidative Stress and Enhancing Immune Responses
Current Medicinal Chemistry Intravitreal Injections and Diabetic Macular Edema: Actual and New Therapeutic Options
Current Diabetes Reviews Signaling Pathways Involved in Physiopathology of Pancreatic β -Cells
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Editorial [Hot Topic: Molecular Imaging in Current Pharmaceuticals (Guest Editor: Ramasamy Paulmurugan)]
Current Pharmaceutical Biotechnology Megsin Gene: Its Genomic Analysis, Pathobiological Functions, and Therapeutic Perspectives
Current Genomics Editorial [Hot Topic: New Paradigms in Drug Formulation and Phytotherapeutics (Guest Editor: Shyam M. Rele)]
Current Bioactive Compounds The IGF Axis in Prostate Cancer
Current Pharmaceutical Design